Rieger anomaly

disease
On this page

Summary

Rieger anomaly (MONDO:0019628) is a disease with 7 cohort genes.

At a glance

  • Cohort genes: 7
  • ClinVar variants: 8

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameRieger anomaly
Mondo IDMONDO:0019628
Orphanet91483
UMLSC0265341
MedGen78558
GARD0016482
MedDRA10059198
Is cancer (heuristic)no

Data availability: 8 ClinVar variants · 2 GenCC gene-disease records · 2 cell lines.

Disease family

An umbrella term covering 1 Mondo subtype.

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary diseaseanterior segment dysgenesis › iridogoniodysgenesis › Rieger anomaly

Related subtypes (6): congenital microcoria, aniridia-cerebellar ataxia-intellectual disability syndrome, chromosome 6pter-p24 deletion syndrome, bilateral acute depigmentation of the iris, congenital ectropion uveae, FOXC1-related anterior segment dysgenesis

Subtypes (1): anterior segment dysgenesis 4

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

8 retrieved; paginated sample, class counts are floors:

3 conflicting classifications of pathogenicity, 3 likely benign, 1 likely pathogenic, 1 pathogenic

ClinVarVariant (HGVS)GeneClassificationReview
492756NM_000325.6(PITX2):c.307C>T (p.Gln103Ter)PITX2Pathogeniccriteria provided, single submitter
26802246;XY;t(2;4)(p23;q27)dnLikely pathogeniccriteria provided, single submitter
221949NM_025074.7(FRAS1):c.3700G>A (p.Ala1234Thr)FRAS1Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
30767NM_001379081.2(FREM1):c.1493G>A (p.Arg498Gln)FREM1Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
132723NM_000264.5(PTCH1):c.3947A>G (p.Tyr1316Cys)PTCH1Conflicting classifications of pathogenicitycriteria provided, conflicting classifications
221947NM_024533.4(CHST5):c.737T>C (p.Ile246Thr)CHST5Likely benigncriteria provided, single submitter
221948NM_001079520.2(DACT1):c.1899G>C (p.Lys633Asn)DACT1Likely benigncriteria provided, single submitter
132738NM_000264.5(PTCH1):c.3889C>T (p.Arg1297Trp)PTCH1Likely benigncriteria provided, multiple submitters, no conflicts

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 25 · Orphanet: 29 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

GenCC gene–disease validity (cohort genes)

the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.

GeneClassificationInheritanceDiseaseRecords
FOXC1DefinitiveAutosomal dominantAxenfeld-Rieger syndrome type 310
PITX2DefinitiveAutosomal dominantAxenfeld-Rieger syndrome type 115

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
PITX2Orphanet:334Hereditary atrial fibrillation
PITX2Orphanet:708Peters anomaly
PITX2Orphanet:782Axenfeld-Rieger syndrome
PITX2Orphanet:91481Ring dermoid of cornea
PITX2Orphanet:91483Rieger anomaly
PITX2Orphanet:98978Axenfeld anomaly
FOXC1Orphanet:250923Isolated aniridia
FOXC1Orphanet:708Peters anomaly
FOXC1Orphanet:782Axenfeld-Rieger syndrome
FOXC1Orphanet:91483Rieger anomaly
FOXC1Orphanet:98978Axenfeld anomaly
DACT1Orphanet:268823Occipital encephalocele
DACT1Orphanet:63260Craniorachischisis
DACT1Orphanet:857Townes-Brocks syndrome
FRAS1Orphanet:2052Fraser syndrome
FRAS1Orphanet:93100Renal agenesis, unilateral
FREM1Orphanet:217266BNAR syndrome
FREM1Orphanet:2717Oculotrichoanal syndrome
FREM1Orphanet:3366Non-syndromic metopic craniosynostosis
FREM1Orphanet:93100Renal agenesis, unilateral
PTCH1Orphanet:220386Semilobar holoprosencephaly
PTCH1Orphanet:2353Schilbach-Rott syndrome
PTCH1Orphanet:280195Septopreoptic holoprosencephaly
PTCH1Orphanet:280200Microform holoprosencephaly
PTCH1Orphanet:377Gorlin syndrome
PTCH1Orphanet:77301Monosomy 9q22.3 syndrome
PTCH1Orphanet:93924Lobar holoprosencephaly
PTCH1Orphanet:93925Alobar holoprosencephaly
PTCH1Orphanet:93926Midline interhemispheric variant of holoprosencephaly

Cohort genes → proteins

7 cohort genes, 7 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence7

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
PITX2HGNC:9005ENSG00000164093Q99697Pituitary homeobox 2gencc,clinvar
FOXC1HGNC:3800ENSG00000054598Q12948Forkhead box protein C1gencc
DACT1HGNC:17748ENSG00000165617Q9NYF0Dapper homolog 1clinvar
FRAS1HGNC:19185ENSG00000138759Q86XX4Extracellular matrix organizing protein FRAS1clinvar
CHST5HGNC:1973ENSG00000135702Q9GZS9Carbohydrate sulfotransferase 5clinvar
FREM1HGNC:23399ENSG00000164946Q5H8C1FRAS1-related extracellular matrix protein 1clinvar
PTCH1HGNC:9585ENSG00000185920Q13635Protein patched homolog 1clinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
PITX2Pituitary homeobox 2May play a role in myoblast differentiation.
FOXC1Forkhead box protein C1DNA-binding transcriptional factor that plays a role in a broad range of cellular and developmental processes such as eye, bones, cardiovascular, kidney and skin development.
DACT1Dapper homolog 1Involved in regulation of intracellular signaling pathways during development.
FRAS1Extracellular matrix organizing protein FRAS1Involved in extracellular matrix organization.
CHST5Carbohydrate sulfotransferase 5Sulfotransferase that utilizes 3’-phospho-5’-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues and O-linked sugars of mucin-type acceptors.
FREM1FRAS1-related extracellular matrix protein 1Extracellular matrix protein that plays a role in epidermal differentiation and is required for epidermal adhesion during embryonic development.
PTCH1Protein patched homolog 1Acts as a receptor for sonic hedgehog (SHH), indian hedgehog (IHH) and desert hedgehog (DHH).

Protein-family classification

Druggable: 0 · Difficult: 2 · Unknown: 5 · Druggable fraction: 0.0

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Transcription factor22.4×0.332
Other/Unknown51.3×0.332

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
PITX2Transcription factornoHD, OAR_dom, Homeodomain-like_sf
FOXC1Transcription factornoFork_head_dom, TF_fork_head_CS_1, TF_fork_head_CS_2
DACT1Other/UnknownnoDapper
FRAS1Other/UnknownnoEGF, VWF_dom, Calx_beta
CHST5Other/UnknownnoSulfotransferase_dom, Carbohydrate_sulfotransferase, P-loop_NTPase
FREM1Other/UnknownnoC-type_lectin-like, Calx_beta, C-type_lectin-like/link_sf
PTCH1Other/UnknownnoSSD, TM_rcpt_patched, HMGCR/SNAP/NPC1-like_SSD

Expression context

Cohort genes with no expression data: 0.

7 cohort genes are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)7
unknown0

Top tissues across cohort

TissueCohort genes
trigeminal ganglion2
biceps brachii1
gingiva1
gingival epithelium1
parotid gland1
vena cava1
cortical plate1
gall bladder1
right coronary artery1
germinal epithelium of ovary1
parietal pleura1
renal medulla1
duodenum1
mucosa of transverse colon1
rectum1
kidney epithelium1
metanephros1
smooth muscle tissue1
dorsal root ganglion1
tibia1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
PITX2166broadmarkergingiva, biceps brachii, gingival epithelium
FOXC1267ubiquitousmarkerparotid gland, vena cava, trigeminal ganglion
DACT1200ubiquitousmarkercortical plate, right coronary artery, gall bladder
FRAS1212ubiquitousmarkergerminal epithelium of ovary, parietal pleura, renal medulla
CHST5117tissue_specificmarkerduodenum, rectum, mucosa of transverse colon
FREM1171broadmarkerkidney epithelium, smooth muscle tissue, metanephros
PTCH1275ubiquitousmarkertibia, dorsal root ganglion, trigeminal ganglion

Protein interactions among cohort

Intra-cohort edges: 2.

Hub genes (top 10 by interactor count)

SymbolInteractor count
PTCH13,368
FOXC12,896
FRAS12,552
PITX22,389
FREM11,541
DACT11,107
CHST5355

Intra-cohort edges

ABSources
FOXC1PITX2intact, string_interaction
FRAS1FREM1string_interaction

Structural data

PDB: 2 · AlphaFold-only: 5 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
PTCH1Q1363516
PITX2Q996973

AlphaFold-only cohort genes (top 30 by pLDDT)

SymbolUniProtpLDDT
CHST5Q9GZS988.60
FREM1Q5H8C175.75
FOXC1Q1294856.09
DACT1Q9NYF050.95
FRAS1Q86XX4

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 11. Enrichment computed across 7 evidence-associated genes (5 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 5 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
TFAP2 (AP-2) family regulates transcription of other transcription factors1571.0×0.010PITX2
GLI proteins bind promoters of Hh responsive genes to promote transcription1326.3×0.010PTCH1
Ligand-receptor interactions1285.5×0.010PTCH1
Formation of intermediate mesoderm1285.5×0.010FOXC1
Activation of SMO1126.9×0.017PTCH1
Formation of the ureteric bud199.3×0.018FOXC1
Keratan sulfate biosynthesis176.1×0.021CHST5
Degradation of DVL147.6×0.029DACT1
Class B/2 (Secretin family receptors)138.1×0.030PTCH1
Hedgehog ‘off’ state135.7×0.030PTCH1
Hedgehog ‘on’ state131.7×0.031PTCH1

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 7 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
anatomical structure morphogenesis479.6×1e-05PITX2, FRAS1, FREM1, FOXC1
cell communication2240.7×0.002FRAS1, FREM1
in utero embryonic development330.9×0.005PITX2, FOXC1, PTCH1
embryonic limb morphogenesis2114.6×0.005FRAS1, PTCH1
camera-type eye development2102.4×0.005PITX2, FOXC1
subthalamic nucleus development12407.4×0.007PITX2
superior vena cava morphogenesis12407.4×0.007PITX2
glomerular epithelium development12407.4×0.007FOXC1
positive regulation of hematopoietic stem cell differentiation12407.4×0.007FOXC1
apoptotic process involved in outflow tract morphogenesis11203.7×0.007FOXC1
response to chlorate11203.7×0.007PTCH1
hypothalamus cell migration11203.7×0.007PITX2
neural plate axis specification11203.7×0.007PTCH1
prolactin secreting cell differentiation11203.7×0.007PITX2
left lung morphogenesis11203.7×0.007PITX2
pulmonary vein morphogenesis11203.7×0.007PITX2
cell proliferation involved in outflow tract morphogenesis11203.7×0.007PITX2
cell proliferation involved in metanephros development11203.7×0.007PTCH1
negative regulation of apoptotic process involved in outflow tract morphogenesis11203.7×0.007FOXC1
positive regulation of core promoter binding11203.7×0.007FOXC1
negative regulation of transcription by RNA polymerase II410.1×0.007PITX2, DACT1, FOXC1, PTCH1
pulmonary myocardium development1802.5×0.007PITX2
protein sulfation1802.5×0.007CHST5
vascular associated smooth muscle cell differentiation1802.5×0.007PITX2
deltoid tuberosity development1802.5×0.007PITX2
embryonic hindgut morphogenesis1802.5×0.007DACT1
cell differentiation involved in kidney development1802.5×0.007PTCH1
endodermal digestive tract morphogenesis1802.5×0.007PITX2
negative regulation of lymphangiogenesis1802.5×0.007FOXC1
positive regulation of hematopoietic progenitor cell differentiation1802.5×0.007FOXC1

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 7

Druggability breadth: 1 of 7 evidence-associated genes (14%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
PITX200
FOXC100
DACT100
FRAS100
CHST500
FREM100
PTCH100

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 0.

Cohort genes with ChEMBL bioactivity (full, sorted by assay count)

SymbolAssaysType breakdown
PTCH14Binding:4

Pharmacogenomics

Cohort genes with a PharmGKB record: 7; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug0
DDruggable family + AlphaFold only, no drug0
EDifficult family or no structure, no drug7PITX2, FOXC1, DACT1, FRAS1, CHST5, FREM1, PTCH1

Undrugged target profiles

7 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
PITX20
FOXC10
DACT10
FRAS10
CHST50
FREM10
PTCH14

Clinical trials & evidence

Clinical trials

Clinical trials: 0.